Skip to main content
. 2022 May 27;188(2):198–207. doi: 10.1093/toxsci/kfac053

Figure 3.

Figure 3.

The BMC difference of the concordantly active compounds between pairs of laboratories in 3 categories of endpoints (mortality, cumulative devtox, and neurotox). Each dot represents a compound and is colored based on its category (eg, drug). The violin plot is used to show the distribution of the dots. The 25th, 50th, and 75th percentiles of the distribution are shown as black lines in the violin. The red dashed line is equivalent to 0, meaning there is no potency difference. Compounds that are 10-fold more potent/less potent are labeled. The names in the cumulative devtox panel: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), dieldrin, aldicarb, dibenz(a, h)anthracene, pyrene, valinomycin, firemaster 550, dichlorodiphenyltrichloroethane (DDT), phenol, isopropylated, phosphate (3:1), and deltamethrin. A color version of this figure appears in the online version of this article.